Related Experiment Video
Updated: Apr 3, 2026

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
Published on: October 13, 2016
Ocular motor signatures of cognitive dysfunction in multiple sclerosis
Joanne Fielding1,2, Meaghan Clough1, Shin Beh3
1School of Psychological Sciences and Monash Institute of Cognitive and Clinical Neurosciences, Monash University, Wellington Road, Clayton, VIC 3800, Australia.
Ocular motility measures may offer sensitive, objective assessments of cognitive dysfunction in multiple sclerosis (MS). This approach could refine diagnosis, prognostication, and monitoring of neurotherapeutics for MS.
Area of Science:
- Neuroscience
- Ophthalmology
- Neurology
Background:
- Cognitive dysfunction is a significant challenge in multiple sclerosis (MS).
- Ocular motor control shares neural circuitry with cognitive networks.
- Existing cognitive assessments can be subjective and lack reproducibility.
Purpose of the Study:
- To explore the potential of ocular motility measures as sensitive biomarkers for cognitive dysfunction in MS.
- To discuss how these measures can aid in diagnosis, prognostication, and monitoring of MS.
- To highlight the role of ocular measures in evaluating neurotherapeutics for MS.
Main Methods:
- Review of existing literature on ocular motor function and cognitive networks in MS.
- Analysis of the overlap between ocular motor command circuitry and higher-order cognitive networks.
- Discussion of the application of ocular motility measures as objective biomarkers.
Main Results:
- Ocular motility measures demonstrate potential for sensitive and objective assessment of cognitive impairment in MS.
- These measures can reflect disruptions in wide-ranging neural networks supporting cognition.
- Potential for use in refining diagnosis, prognostication, and disease burden assessment in MS.
Conclusions:
- Ocular motility assessment presents a promising, objective tool for evaluating cognitive function in multiple sclerosis.
- This approach may enhance the monitoring of disease progression and therapeutic interventions in MS.
- Further validation could lead to novel biomarkers for MS research and clinical practice.
More Related Videos
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
07:30Efficiently Recording the Eye-Hand Coordination to Incoordination Spectrum
Published on: March 21, 2019
Related Concept Videos
Visual Agnosia
Prosopagnosia